NCT03375307 2026-06-05Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic ChangesNational Cancer Institute (NCI)Phase 2 Suspended60 enrolled